Soltis Investment Advisors LLC Buys 462 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Soltis Investment Advisors LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,656 shares of the company’s stock after purchasing an additional 462 shares during the period. Soltis Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $208,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in GEHC. Savant Capital LLC increased its position in shares of GE HealthCare Technologies by 149.7% during the 4th quarter. Savant Capital LLC now owns 27,585 shares of the company’s stock valued at $2,157,000 after purchasing an additional 16,538 shares during the last quarter. Coronation Fund Managers Ltd. purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at approximately $26,189,000. Tevis Investment Management purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at approximately $1,005,000. Entropy Technologies LP bought a new position in GE HealthCare Technologies in the fourth quarter worth approximately $1,666,000. Finally, Empowered Funds LLC boosted its stake in shares of GE HealthCare Technologies by 15.8% during the 4th quarter. Empowered Funds LLC now owns 27,183 shares of the company’s stock worth $2,125,000 after acquiring an additional 3,713 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $87.03 on Wednesday. The stock has a 50-day moving average price of $83.52 and a 200 day moving average price of $85.38. The stock has a market capitalization of $39.76 billion, a P/E ratio of 23.91, a P/E/G ratio of 2.93 and a beta of 1.15. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on GEHC shares. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.